世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
細胞凍結保存市場：タイプ別（凍結保存培地、装置）、用途別（幹細胞、卵母細胞、精子細胞、その他）、エンドユーザー別（製薬・バイオ企業、研究機関、その他）：世界の機会分析と産業予測、2023-2032年Cell Cryopreservation Market By Type (Cryopreservation media, Equipment), By Application (Stem cells, Oocytes cells, Sperm cells, Others), By End User (Pharmaceutical and biotechnology company, Research institute, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 細胞凍結保存の市場規模は2022年に103億ドルと評価され、2023年から2032年までの年平均成長率は22.2%で、2032年には766億ドルに達すると予測されている。凍結保存とは、細胞小器官、細胞、組織、その他の生物学的... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー細胞凍結保存の市場規模は2022年に103億ドルと評価され、2023年から2032年までの年平均成長率は22.2%で、2032年には766億ドルに達すると予測されている。凍結保存とは、細胞小器官、細胞、組織、その他の生物学的構成要素を超低温（-80℃～-196℃）で凍結し、細胞代謝を停止させることにより、細胞を無期限に保存することである。低温では、生きている細胞の生物学的・化学的反応は劇的に低下する。したがって、凍結保存は細胞の完全性と機能性を維持する上で重要な役割を果たし、生物学研究のワークフローに適している。細胞内の水分が凍結すると、氷の形成によって溶質のバランスが崩れ、細胞構造が損傷する可能性がある。従って、適切な凍結保護剤と添加剤を含む凍結培地と技術を適切に使用することで、研究者は細胞培養のための細胞の解凍後の生存率を最大化することができる。世界の細胞凍結保存市場の成長は、女性の不妊症の増加と卵子凍結サイクルの増加によって大きく左右される。The Society for Assisted Reproductive Technology（生殖補助技術協会）によると、米国では2020年から2021年にかけて卵子凍結サイクルが31％増加すると報告されている。バイオバンクは、生物医学研究、創薬、個別化医療を促進する上で極めて重要な役割を担っているため、注目を集めている。バイオバンク・リソース・センターによると、2023年現在、カナダと国際的なバイオバンクを含め340のバイオバンクが登録されている。 さらに、Journal of Biopreservation and Biobankingによると、2022年には、BBMRIのディレクトリに17カ国641のバイオバンクが登録されていると報告されている（2021年2月12日現在）。バイオバンキング技術の進歩や、より大規模で包括的なバイオバンクの設立に伴い、効率的で信頼性の高い細胞凍結保存法の需要は著しく高まっている。さらに、製薬業界やバイオテクノロジー業界における研究開発活動の増加、研究開発活動に対する政府支援の増加、癌やパーキンソン病などの慢性疾患の有病率の増加が市場の成長を後押ししている。 さらに、国立医学図書館によると、2022年には、網膜疾患、パーキンソン病、ハンチントン病、脊髄損傷、心筋梗塞、1型糖尿病などの幅広い疾患の治療のために、胚性幹細胞でさまざまな前臨床研究活動が行われていると報告されている。さらに、インド政府は、インド医学研究評議会（ICMR）、バイオテクノロジー省（DBT）、科学技術省（DST）などの国家助成機関を通じて、基礎研究だけでなく臨床研究も支援することで、さまざまな省庁や機関を通じて幹細胞研究を実施している。 さらに、Regulatory Affairs Professionals Societyによると、2021年には約2,754のクリニックが幹細胞治療を提供している。その結果、幹細胞治療に対する需要の高まりは、細胞凍結保存市場の重要な促進要因となっている。さらに、個別化医療に対する需要の急増は、細胞凍結保存市場の重要なドライバーとして機能すると予想される。免疫細胞ベースの免疫療法や人工細胞療法などの細胞ベースの治療法は、個別化治療のアプローチとして研究されている。凍結保存は、免疫細胞を含む患者特異的な細胞の長期保存を可能にし、個別化治療の開発に利用できる。 これらの細胞を保存することで、凍結保存は患者特異的治療に必要な時に利用可能であることを保証する。個別化医療への関心が高まるにつれ、細胞凍結保存法や保存施設への需要も同時に高まり、世界市場の成長を後押ししている。さらに、不妊率の上昇も市場の成長に大きく寄与している。しかし、細胞凍結保存の代替療法が利用可能であることや、保存手順の維持コストが高いことが、市場の成長を妨げている。 世界の細胞凍結保存市場は、タイプ、用途、エンドユーザー、地域に区分される。タイプ別では、凍結保存培地と機器に二分される。凍結保存培地セグメントはさらにエチレングリコール、ジメチルスルホキシド、グリセロール、その他に細分化される。機器セグメントはフリーザー、液体窒素供給タンク、その他に細分化される。 用途別では、幹細胞、卵細胞、精子細胞、その他に分類される。エンドユーザー別では、製薬・バイオテクノロジー企業、研究機関、その他に分類される。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（中国、日本、オーストラリア、インド、その他アジア太平洋）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他LAMEA）で調査されている。本レポートに掲載されている主要企業には、Merck Group KGaA、HiMedia Laboratories、Thermo Fisher Scientific Inc.エッペンドルフ社、バイオライフ・ソリューションズ社、ロンザ社、サルトリウス社、クリエイティブ・バイオラボズ社、サルトリウス社、プロモセル社などである。 ステークホルダーにとっての主なメリット 本レポートは、2021年から2031年までの細胞凍結保存市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、細胞凍結保存市場の有力な機会を特定します。 市場調査は主要な促進要因、阻害要因、機会に関する情報とともに提供されます。 ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。 細胞凍結保存市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。 各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。 市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。 地域別および世界の細胞凍結保存市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。 主要市場セグメント タイプ別 凍結保存培地 薬剤 エチレングリコール ジメチルスルホキシド グリセロール その他 装置 種類 フリーザー 液体窒素供給タンク その他 用途別 幹細胞 卵子細胞 精子細胞 その他 エンドユーザー別 製薬・バイオテクノロジー企業 研究機関 その他 地域別 北米 米国 カナダ メキシコ ヨーロッパ ドイツ フランス イギリス イタリア スペイン その他のヨーロッパ アジア太平洋 日本 中国 インド オーストラリア 韓国 マレーシア その他のアジア太平洋地域 ラメア ブラジル 南アフリカ サウジアラビア その他の地域 主要市場プレイヤー バイオライフ・ソリューションズ社 クリエイティブ・バイオラボ ダナハーコーポレーション エッペンドルフ・コーポレート ハイメディア・ラボラトリーズ ロンザ メルクグループ KGaA プロモセルGmbH ザルトリウスAG サーモフィッシャーサイエンティフィック 目次CHAPTER 1: INTRODUCTION1.1. Report description 1.2. Key market segments 1.3. Key benefits to the stakeholders 1.4. Research Methodology 1.4.1. Primary research 1.4.2. Secondary research 1.4.3. Analyst tools and models CHAPTER 2: EXECUTIVE SUMMARY 2.1. CXO Perspective CHAPTER 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top impacting factors 3.2.2. Top investment pockets 3.3. Porter’s five forces analysis 3.3.1. Low bargaining power of suppliers 3.3.2. Low threat of new entrants 3.3.3. Low threat of substitutes 3.3.4. Low intensity of rivalry 3.3.5. Low bargaining power of buyers 3.4. Market dynamics 3.4.1. Drivers 3.4.1.1. Increase in number of egg freezing cycles 3.4.1.2. Increase in research and development activities for stem cells 3.4.1.3. Rise in number of biobanks and surge in demand for personalized medicines 3.4.2. Restraints 3.4.2.1. Availability of alternative therapies for cell cryopreservation 3.4.3. Opportunities 3.4.3.1. Increase in government support for research and development activities 3.4.3.2. Rise in focus of manufacturers on developing novel products for preserving various cells 3.5. COVID-19 Impact Analysis on the market 3.6. Patent Landscape CHAPTER 4: CELL CRYOPRESERVATION MARKET, BY TYPE 4.1. Overview 4.1.1. Market size and forecast 4.2. Cryopreservation media 4.2.1. Key market trends, growth factors and opportunities 4.2.2. Market size and forecast, by region 4.2.3. Market share analysis by country 4.2.4. Cryopreservation media Cell Cryopreservation Market by Agent 4.3. Equipment 4.3.1. Key market trends, growth factors and opportunities 4.3.2. Market size and forecast, by region 4.3.3. Market share analysis by country 4.3.4. Equipment Cell Cryopreservation Market by Type CHAPTER 5: CELL CRYOPRESERVATION MARKET, BY APPLICATION 5.1. Overview 5.1.1. Market size and forecast 5.2. Stem cells 5.2.1. Key market trends, growth factors and opportunities 5.2.2. Market size and forecast, by region 5.2.3. Market share analysis by country 5.3. Oocytes cells 5.3.1. Key market trends, growth factors and opportunities 5.3.2. Market size and forecast, by region 5.3.3. Market share analysis by country 5.4. Sperm cells 5.4.1. Key market trends, growth factors and opportunities 5.4.2. Market size and forecast, by region 5.4.3. Market share analysis by country 5.5. Others 5.5.1. Key market trends, growth factors and opportunities 5.5.2. Market size and forecast, by region 5.5.3. Market share analysis by country CHAPTER 6: CELL CRYOPRESERVATION MARKET, BY END USER 6.1. Overview 6.1.1. Market size and forecast 6.2. Pharmaceutical and biotechnology company 6.2.1. Key market trends, growth factors and opportunities 6.2.2. Market size and forecast, by region 6.2.3. Market share analysis by country 6.3. Research institute 6.3.1. Key market trends, growth factors and opportunities 6.3.2. Market size and forecast, by region 6.3.3. Market share analysis by country 6.4. Others 6.4.1. Key market trends, growth factors and opportunities 6.4.2. Market size and forecast, by region 6.4.3. Market share analysis by country CHAPTER 7: CELL CRYOPRESERVATION MARKET, BY REGION 7.1. Overview 7.1.1. Market size and forecast By Region 7.2. North America 7.2.1. Key trends and opportunities 7.2.2. Market size and forecast, by Type 7.2.3. Market size and forecast, by Application 7.2.4. Market size and forecast, by End User 7.2.5. Market size and forecast, by country 7.2.5.1. U.S. 7.2.5.1.1. Key market trends, growth factors and opportunities 7.2.5.1.2. Market size and forecast, by Type 7.2.5.1.3. Market size and forecast, by Application 7.2.5.1.4. Market size and forecast, by End User 7.2.5.2. Canada 7.2.5.2.1. Key market trends, growth factors and opportunities 7.2.5.2.2. Market size and forecast, by Type 7.2.5.2.3. Market size and forecast, by Application 7.2.5.2.4. Market size and forecast, by End User 7.2.5.3. Mexico 7.2.5.3.1. Key market trends, growth factors and opportunities 7.2.5.3.2. Market size and forecast, by Type 7.2.5.3.3. Market size and forecast, by Application 7.2.5.3.4. Market size and forecast, by End User 7.3. Europe 7.3.1. Key trends and opportunities 7.3.2. Market size and forecast, by Type 7.3.3. Market size and forecast, by Application 7.3.4. Market size and forecast, by End User 7.3.5. Market size and forecast, by country 7.3.5.1. Germany 7.3.5.1.1. Key market trends, growth factors and opportunities 7.3.5.1.2. Market size and forecast, by Type 7.3.5.1.3. Market size and forecast, by Application 7.3.5.1.4. Market size and forecast, by End User 7.3.5.2. France 7.3.5.2.1. Key market trends, growth factors and opportunities 7.3.5.2.2. Market size and forecast, by Type 7.3.5.2.3. Market size and forecast, by Application 7.3.5.2.4. Market size and forecast, by End User 7.3.5.3. UK 7.3.5.3.1. Key market trends, growth factors and opportunities 7.3.5.3.2. Market size and forecast, by Type 7.3.5.3.3. Market size and forecast, by Application 7.3.5.3.4. Market size and forecast, by End User 7.3.5.4. Italy 7.3.5.4.1. Key market trends, growth factors and opportunities 7.3.5.4.2. Market size and forecast, by Type 7.3.5.4.3. Market size and forecast, by Application 7.3.5.4.4. Market size and forecast, by End User 7.3.5.5. Spain 7.3.5.5.1. Key market trends, growth factors and opportunities 7.3.5.5.2. Market size and forecast, by Type 7.3.5.5.3. Market size and forecast, by Application 7.3.5.5.4. Market size and forecast, by End User 7.3.5.6. Rest of Europe 7.3.5.6.1. Key market trends, growth factors and opportunities 7.3.5.6.2. Market size and forecast, by Type 7.3.5.6.3. Market size and forecast, by Application 7.3.5.6.4. Market size and forecast, by End User 7.4. Asia-Pacific 7.4.1. Key trends and opportunities 7.4.2. Market size and forecast, by Type 7.4.3. Market size and forecast, by Application 7.4.4. Market size and forecast, by End User 7.4.5. Market size and forecast, by country 7.4.5.1. Japan 7.4.5.1.1. Key market trends, growth factors and opportunities 7.4.5.1.2. Market size and forecast, by Type 7.4.5.1.3. Market size and forecast, by Application 7.4.5.1.4. Market size and forecast, by End User 7.4.5.2. China 7.4.5.2.1. Key market trends, growth factors and opportunities 7.4.5.2.2. Market size and forecast, by Type 7.4.5.2.3. Market size and forecast, by Application 7.4.5.2.4. Market size and forecast, by End User 7.4.5.3. India 7.4.5.3.1. Key market trends, growth factors and opportunities 7.4.5.3.2. Market size and forecast, by Type 7.4.5.3.3. Market size and forecast, by Application 7.4.5.3.4. Market size and forecast, by End User 7.4.5.4. Australia 7.4.5.4.1. Key market trends, growth factors and opportunities 7.4.5.4.2. Market size and forecast, by Type 7.4.5.4.3. Market size and forecast, by Application 7.4.5.4.4. Market size and forecast, by End User 7.4.5.5. South Korea 7.4.5.5.1. Key market trends, growth factors and opportunities 7.4.5.5.2. Market size and forecast, by Type 7.4.5.5.3. Market size and forecast, by Application 7.4.5.5.4. Market size and forecast, by End User 7.4.5.6. Malaysia 7.4.5.6.1. Key market trends, growth factors and opportunities 7.4.5.6.2. Market size and forecast, by Type 7.4.5.6.3. Market size and forecast, by Application 7.4.5.6.4. Market size and forecast, by End User 7.4.5.7. Rest of Asia-Pacific 7.4.5.7.1. Key market trends, growth factors and opportunities 7.4.5.7.2. Market size and forecast, by Type 7.4.5.7.3. Market size and forecast, by Application 7.4.5.7.4. Market size and forecast, by End User 7.5. LAMEA 7.5.1. Key trends and opportunities 7.5.2. Market size and forecast, by Type 7.5.3. Market size and forecast, by Application 7.5.4. Market size and forecast, by End User 7.5.5. Market size and forecast, by country 7.5.5.1. Brazil 7.5.5.1.1. Key market trends, growth factors and opportunities 7.5.5.1.2. Market size and forecast, by Type 7.5.5.1.3. Market size and forecast, by Application 7.5.5.1.4. Market size and forecast, by End User 7.5.5.2. South Africa, 7.5.5.2.1. Key market trends, growth factors and opportunities 7.5.5.2.2. Market size and forecast, by Type 7.5.5.2.3. Market size and forecast, by Application 7.5.5.2.4. Market size and forecast, by End User 7.5.5.3. Saudi Arabia 7.5.5.3.1. Key market trends, growth factors and opportunities 7.5.5.3.2. Market size and forecast, by Type 7.5.5.3.3. Market size and forecast, by Application 7.5.5.3.4. Market size and forecast, by End User 7.5.5.4. Rest of LAMEA 7.5.5.4.1. Key market trends, growth factors and opportunities 7.5.5.4.2. Market size and forecast, by Type 7.5.5.4.3. Market size and forecast, by Application 7.5.5.4.4. Market size and forecast, by End User CHAPTER 8: COMPETITIVE LANDSCAPE 8.1. Introduction 8.2. Top winning strategies 8.3. Product Mapping of Top 10 Player 8.4. Competitive Dashboard 8.5. Competitive Heatmap 8.6. Top player positioning, 2022 CHAPTER 9: COMPANY PROFILES 9.1. Creative Biolabs 9.1.1. Company overview 9.1.2. Key Executives 9.1.3. Company snapshot 9.1.4. Operating business segments 9.1.5. Product portfolio 9.2. Eppendorf Corporate 9.2.1. Company overview 9.2.2. Key Executives 9.2.3. Company snapshot 9.2.4. Operating business segments 9.2.5. Product portfolio 9.2.6. Business performance 9.2.7. Key strategic moves and developments 9.3. Lonza 9.3.1. Company overview 9.3.2. Key Executives 9.3.3. Company snapshot 9.3.4. Operating business segments 9.3.5. Product portfolio 9.3.6. Business performance 9.4. PromoCell GmbH 9.4.1. Company overview 9.4.2. Key Executives 9.4.3. Company snapshot 9.4.4. Operating business segments 9.4.5. Product portfolio 9.5. Sartorius AG 9.5.1. Company overview 9.5.2. Key Executives 9.5.3. Company snapshot 9.5.4. Operating business segments 9.5.5. Product portfolio 9.5.6. Business performance 9.6. BioLife Solutions, Inc. 9.6.1. Company overview 9.6.2. Key Executives 9.6.3. Company snapshot 9.6.4. Operating business segments 9.6.5. Product portfolio 9.6.6. Business performance 9.6.7. Key strategic moves and developments 9.7. Danaher Corporation 9.7.1. Company overview 9.7.2. Key Executives 9.7.3. Company snapshot 9.7.4. Operating business segments 9.7.5. Product portfolio 9.7.6. Business performance 9.7.7. Key strategic moves and developments 9.8. Thermo Fisher Scientific Inc. 9.8.1. Company overview 9.8.2. Key Executives 9.8.3. Company snapshot 9.8.4. Operating business segments 9.8.5. Product portfolio 9.8.6. Business performance 9.8.7. Key strategic moves and developments 9.9. HiMedia Laboratories 9.9.1. Company overview 9.9.2. Key Executives 9.9.3. Company snapshot 9.9.4. Operating business segments 9.9.5. Product portfolio 9.10. Merck Group KGaA 9.10.1. Company overview 9.10.2. Key Executives 9.10.3. Company snapshot 9.10.4. Operating business segments 9.10.5. Product portfolio 9.10.6. Business performance
SummaryThe cell cryopreservation market size was valued at $10.3 billion in 2022, and is projected to reach $76.6 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.. Cryopreservation involves the preservation of organelles, cells, tissues, or any other biological component by freezing them at very low temperatures (−80°C to −196°C) and suspending their cellular metabolism, which preserves the cells for an indefinite amount of time. At low temperatures, biological and chemical reactions in living cells are dramatically reduced. Thus, cryopreservation plays a vital role in maintaining the integrity and functionality of cells, which make it suitable for biological research workflows. When water within cells freezes, ice formation can cause a solute imbalance and damage the cellular structure. Thus, the proper usage of techniques and a freezing medium containing the right cryoprotectants and additives can help researchers to maximize the post-thaw viability of cells for cell culture. Table of ContentsCHAPTER 1: INTRODUCTION1.1. Report description 1.2. Key market segments 1.3. Key benefits to the stakeholders 1.4. Research Methodology 1.4.1. Primary research 1.4.2. Secondary research 1.4.3. Analyst tools and models CHAPTER 2: EXECUTIVE SUMMARY 2.1. CXO Perspective CHAPTER 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top impacting factors 3.2.2. Top investment pockets 3.3. Porter’s five forces analysis 3.3.1. Low bargaining power of suppliers 3.3.2. Low threat of new entrants 3.3.3. Low threat of substitutes 3.3.4. Low intensity of rivalry 3.3.5. Low bargaining power of buyers 3.4. Market dynamics 3.4.1. Drivers 3.4.1.1. Increase in number of egg freezing cycles 3.4.1.2. Increase in research and development activities for stem cells 3.4.1.3. Rise in number of biobanks and surge in demand for personalized medicines 3.4.2. Restraints 3.4.2.1. Availability of alternative therapies for cell cryopreservation 3.4.3. Opportunities 3.4.3.1. Increase in government support for research and development activities 3.4.3.2. Rise in focus of manufacturers on developing novel products for preserving various cells 3.5. COVID-19 Impact Analysis on the market 3.6. Patent Landscape CHAPTER 4: CELL CRYOPRESERVATION MARKET, BY TYPE 4.1. Overview 4.1.1. Market size and forecast 4.2. Cryopreservation media 4.2.1. Key market trends, growth factors and opportunities 4.2.2. Market size and forecast, by region 4.2.3. Market share analysis by country 4.2.4. Cryopreservation media Cell Cryopreservation Market by Agent 4.3. Equipment 4.3.1. Key market trends, growth factors and opportunities 4.3.2. Market size and forecast, by region 4.3.3. Market share analysis by country 4.3.4. Equipment Cell Cryopreservation Market by Type CHAPTER 5: CELL CRYOPRESERVATION MARKET, BY APPLICATION 5.1. Overview 5.1.1. Market size and forecast 5.2. Stem cells 5.2.1. Key market trends, growth factors and opportunities 5.2.2. Market size and forecast, by region 5.2.3. Market share analysis by country 5.3. Oocytes cells 5.3.1. Key market trends, growth factors and opportunities 5.3.2. Market size and forecast, by region 5.3.3. Market share analysis by country 5.4. Sperm cells 5.4.1. Key market trends, growth factors and opportunities 5.4.2. Market size and forecast, by region 5.4.3. Market share analysis by country 5.5. Others 5.5.1. Key market trends, growth factors and opportunities 5.5.2. Market size and forecast, by region 5.5.3. Market share analysis by country CHAPTER 6: CELL CRYOPRESERVATION MARKET, BY END USER 6.1. Overview 6.1.1. Market size and forecast 6.2. Pharmaceutical and biotechnology company 6.2.1. Key market trends, growth factors and opportunities 6.2.2. Market size and forecast, by region 6.2.3. Market share analysis by country 6.3. Research institute 6.3.1. Key market trends, growth factors and opportunities 6.3.2. Market size and forecast, by region 6.3.3. Market share analysis by country 6.4. Others 6.4.1. Key market trends, growth factors and opportunities 6.4.2. Market size and forecast, by region 6.4.3. Market share analysis by country CHAPTER 7: CELL CRYOPRESERVATION MARKET, BY REGION 7.1. Overview 7.1.1. Market size and forecast By Region 7.2. North America 7.2.1. Key trends and opportunities 7.2.2. Market size and forecast, by Type 7.2.3. Market size and forecast, by Application 7.2.4. Market size and forecast, by End User 7.2.5. Market size and forecast, by country 7.2.5.1. U.S. 7.2.5.1.1. Key market trends, growth factors and opportunities 7.2.5.1.2. Market size and forecast, by Type 7.2.5.1.3. Market size and forecast, by Application 7.2.5.1.4. Market size and forecast, by End User 7.2.5.2. Canada 7.2.5.2.1. Key market trends, growth factors and opportunities 7.2.5.2.2. Market size and forecast, by Type 7.2.5.2.3. Market size and forecast, by Application 7.2.5.2.4. Market size and forecast, by End User 7.2.5.3. Mexico 7.2.5.3.1. Key market trends, growth factors and opportunities 7.2.5.3.2. Market size and forecast, by Type 7.2.5.3.3. Market size and forecast, by Application 7.2.5.3.4. Market size and forecast, by End User 7.3. Europe 7.3.1. Key trends and opportunities 7.3.2. Market size and forecast, by Type 7.3.3. Market size and forecast, by Application 7.3.4. Market size and forecast, by End User 7.3.5. Market size and forecast, by country 7.3.5.1. Germany 7.3.5.1.1. Key market trends, growth factors and opportunities 7.3.5.1.2. Market size and forecast, by Type 7.3.5.1.3. Market size and forecast, by Application 7.3.5.1.4. Market size and forecast, by End User 7.3.5.2. France 7.3.5.2.1. Key market trends, growth factors and opportunities 7.3.5.2.2. Market size and forecast, by Type 7.3.5.2.3. Market size and forecast, by Application 7.3.5.2.4. Market size and forecast, by End User 7.3.5.3. UK 7.3.5.3.1. Key market trends, growth factors and opportunities 7.3.5.3.2. Market size and forecast, by Type 7.3.5.3.3. Market size and forecast, by Application 7.3.5.3.4. Market size and forecast, by End User 7.3.5.4. Italy 7.3.5.4.1. Key market trends, growth factors and opportunities 7.3.5.4.2. Market size and forecast, by Type 7.3.5.4.3. Market size and forecast, by Application 7.3.5.4.4. Market size and forecast, by End User 7.3.5.5. Spain 7.3.5.5.1. Key market trends, growth factors and opportunities 7.3.5.5.2. Market size and forecast, by Type 7.3.5.5.3. Market size and forecast, by Application 7.3.5.5.4. Market size and forecast, by End User 7.3.5.6. Rest of Europe 7.3.5.6.1. Key market trends, growth factors and opportunities 7.3.5.6.2. Market size and forecast, by Type 7.3.5.6.3. Market size and forecast, by Application 7.3.5.6.4. Market size and forecast, by End User 7.4. Asia-Pacific 7.4.1. Key trends and opportunities 7.4.2. Market size and forecast, by Type 7.4.3. Market size and forecast, by Application 7.4.4. Market size and forecast, by End User 7.4.5. Market size and forecast, by country 7.4.5.1. Japan 7.4.5.1.1. Key market trends, growth factors and opportunities 7.4.5.1.2. Market size and forecast, by Type 7.4.5.1.3. Market size and forecast, by Application 7.4.5.1.4. Market size and forecast, by End User 7.4.5.2. China 7.4.5.2.1. Key market trends, growth factors and opportunities 7.4.5.2.2. Market size and forecast, by Type 7.4.5.2.3. Market size and forecast, by Application 7.4.5.2.4. Market size and forecast, by End User 7.4.5.3. India 7.4.5.3.1. Key market trends, growth factors and opportunities 7.4.5.3.2. Market size and forecast, by Type 7.4.5.3.3. Market size and forecast, by Application 7.4.5.3.4. Market size and forecast, by End User 7.4.5.4. Australia 7.4.5.4.1. Key market trends, growth factors and opportunities 7.4.5.4.2. Market size and forecast, by Type 7.4.5.4.3. Market size and forecast, by Application 7.4.5.4.4. Market size and forecast, by End User 7.4.5.5. South Korea 7.4.5.5.1. Key market trends, growth factors and opportunities 7.4.5.5.2. Market size and forecast, by Type 7.4.5.5.3. Market size and forecast, by Application 7.4.5.5.4. Market size and forecast, by End User 7.4.5.6. Malaysia 7.4.5.6.1. Key market trends, growth factors and opportunities 7.4.5.6.2. Market size and forecast, by Type 7.4.5.6.3. Market size and forecast, by Application 7.4.5.6.4. Market size and forecast, by End User 7.4.5.7. Rest of Asia-Pacific 7.4.5.7.1. Key market trends, growth factors and opportunities 7.4.5.7.2. Market size and forecast, by Type 7.4.5.7.3. Market size and forecast, by Application 7.4.5.7.4. Market size and forecast, by End User 7.5. LAMEA 7.5.1. Key trends and opportunities 7.5.2. Market size and forecast, by Type 7.5.3. Market size and forecast, by Application 7.5.4. Market size and forecast, by End User 7.5.5. Market size and forecast, by country 7.5.5.1. Brazil 7.5.5.1.1. Key market trends, growth factors and opportunities 7.5.5.1.2. Market size and forecast, by Type 7.5.5.1.3. Market size and forecast, by Application 7.5.5.1.4. Market size and forecast, by End User 7.5.5.2. South Africa, 7.5.5.2.1. Key market trends, growth factors and opportunities 7.5.5.2.2. Market size and forecast, by Type 7.5.5.2.3. Market size and forecast, by Application 7.5.5.2.4. Market size and forecast, by End User 7.5.5.3. Saudi Arabia 7.5.5.3.1. Key market trends, growth factors and opportunities 7.5.5.3.2. Market size and forecast, by Type 7.5.5.3.3. Market size and forecast, by Application 7.5.5.3.4. Market size and forecast, by End User 7.5.5.4. Rest of LAMEA 7.5.5.4.1. Key market trends, growth factors and opportunities 7.5.5.4.2. Market size and forecast, by Type 7.5.5.4.3. Market size and forecast, by Application 7.5.5.4.4. Market size and forecast, by End User CHAPTER 8: COMPETITIVE LANDSCAPE 8.1. Introduction 8.2. Top winning strategies 8.3. Product Mapping of Top 10 Player 8.4. Competitive Dashboard 8.5. Competitive Heatmap 8.6. Top player positioning, 2022 CHAPTER 9: COMPANY PROFILES 9.1. Creative Biolabs 9.1.1. Company overview 9.1.2. Key Executives 9.1.3. Company snapshot 9.1.4. Operating business segments 9.1.5. Product portfolio 9.2. Eppendorf Corporate 9.2.1. Company overview 9.2.2. Key Executives 9.2.3. Company snapshot 9.2.4. Operating business segments 9.2.5. Product portfolio 9.2.6. Business performance 9.2.7. Key strategic moves and developments 9.3. Lonza 9.3.1. Company overview 9.3.2. Key Executives 9.3.3. Company snapshot 9.3.4. Operating business segments 9.3.5. Product portfolio 9.3.6. Business performance 9.4. PromoCell GmbH 9.4.1. Company overview 9.4.2. Key Executives 9.4.3. Company snapshot 9.4.4. Operating business segments 9.4.5. Product portfolio 9.5. Sartorius AG 9.5.1. Company overview 9.5.2. Key Executives 9.5.3. Company snapshot 9.5.4. Operating business segments 9.5.5. Product portfolio 9.5.6. Business performance 9.6. BioLife Solutions, Inc. 9.6.1. Company overview 9.6.2. Key Executives 9.6.3. Company snapshot 9.6.4. Operating business segments 9.6.5. Product portfolio 9.6.6. Business performance 9.6.7. Key strategic moves and developments 9.7. Danaher Corporation 9.7.1. Company overview 9.7.2. Key Executives 9.7.3. Company snapshot 9.7.4. Operating business segments 9.7.5. Product portfolio 9.7.6. Business performance 9.7.7. Key strategic moves and developments 9.8. Thermo Fisher Scientific Inc. 9.8.1. Company overview 9.8.2. Key Executives 9.8.3. Company snapshot 9.8.4. Operating business segments 9.8.5. Product portfolio 9.8.6. Business performance 9.8.7. Key strategic moves and developments 9.9. HiMedia Laboratories 9.9.1. Company overview 9.9.2. Key Executives 9.9.3. Company snapshot 9.9.4. Operating business segments 9.9.5. Product portfolio 9.10. Merck Group KGaA 9.10.1. Company overview 9.10.2. Key Executives 9.10.3. Company snapshot 9.10.4. Operating business segments 9.10.5. Product portfolio 9.10.6. Business performance
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Allied Market Research社のライフサイエンス分野での最新刊レポート
本レポートと同じKEY WORD（cryopreservation）の最新刊レポートよくあるご質問Allied Market Research社はどのような調査会社ですか?アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |
